Table 2. Distribution of typed MRSA ST398 and other MRSA clinical isolates, by body site, 7 European countries, 2007*.
| Sample source | No. (%) typed clinical isolates |
p value† | |
|---|---|---|---|
| MRSA ST398, n = 113 | Other MRSA, n = 3,435 | ||
| Blood | 2 (1.8) | 343 (10.0) | 0.004 |
| Respiratory tract | 20 (17.7) | 451 (13.1) | 0.16 |
| Skin and wound | 76 (67.3) | 2,312 (67.3) | 0.99 |
| Urinary tract | 6 (5.3) | 173 (5.0) | 0.90 |
| Other | 9 (8.0) | 156 (4.5) | 0.09 |
*Only data from 9 national or regional laboratories in the 7 countries that reported clinical isolates and typed all these isolates were included. Boldface indicates statistical significance (p<0.05). MRSA, methicillin-resistant Staphylococcus aureus; ST398, sequence type 398. †χ2 test.